Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions
about
The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virusGlobal changes in the RNA binding specificity of HIV-1 gag regulate virion genesisThe double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidationStructural determinants and mechanism of HIV-1 genome packagingEfficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signalLocalization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor proteinGene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vectorSecondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retrovirusesPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoThe human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresIs HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usageInhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Psi-RNA.Coordination of Genomic RNA Packaging with Viral Assembly in HIV-1Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro studyCross- and Co-Packaging of Retroviral RNAs and Their ConsequencesOn the Selective Packaging of Genomic RNA by HIV-1The Life-Cycle of the HIV-1 Gag-RNA ComplexIdentification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitroThe bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag geneLipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replicationA third-generation lentivirus vector with a conditional packaging systemInfectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro.Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particlesLive-cell coimaging of the genomic RNAs and Gag proteins of two lentiviruses.Analysis of the initiating events in HIV-1 particle assembly and genome packagingLeader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus.Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation.The bovine leukemia virus encapsidation signal is composed of RNA secondary structures.cis-Acting sequences required for simian foamy virus type 1 vectorsHigh-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activityBasic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques.Partial restoration of replication of simian immunodeficiency virus by point mutations in either the dimerization initiation site (DIS) or Gag region after deletion mutagenesis within the DIS.
P2860
Q24498670-3B331092-7FBE-4FCA-AA6F-53F7681D3718Q24498694-DBB03B10-3412-4BA0-A1E6-1CBE81755296Q24525207-74F2A928-8C75-4F9B-AFC4-E54868D10E91Q24632055-DBDC44BA-CF57-49A4-91B2-726D19351D11Q24645635-83CF5A93-D607-4DE8-B80E-854F51931568Q24645706-E4244D0D-0589-4F6D-B959-7B9ABFEFB475Q24647777-B24DFAA9-62F8-4A9B-808C-348BB46A079DQ24675715-968DE394-57F6-4A3F-9ED2-4D59E3711814Q24678656-22F8F5F1-7F7C-4983-8FE1-1D3B9F12A2ADQ24682817-8662F3E2-9D70-4B88-8CCC-5CCA49E33C0FQ24805927-41E2A2DC-DE72-41E3-B9EE-3A4B8169D6EFQ24810805-24707C1F-D3FB-4009-80D6-257BC0A20AD1Q25255792-B185A3D8-85D4-4A16-A113-9BA33FFC8043Q26739673-E6E18B82-50C2-4B62-89EF-8B5B3A6BC13BQ27485991-A47F42DF-8FEB-4F2D-86A9-E2CB4F21A903Q28066817-848157AF-DB99-42C8-B2D6-C95BA3CFF863Q28071505-FC4CB250-C22A-418B-8268-1BDA22675BC2Q28076985-9E1FA0F2-8DC3-43F7-8FFF-DBDD26D66322Q28254442-FD3B1888-98F3-46C8-A805-934CC473085BQ28301200-502B3ADB-4D3F-4886-AAFD-EE639006AD0AQ28366154-3A0BA8AA-B40C-4A02-8D1B-3E5B69E98394Q29616120-ADE881AE-C3E9-4424-BE74-AF358971C4E3Q30430249-3F667149-E5F7-4C93-A36A-7719104750DAQ30435825-28917B1B-ED27-4C1E-BDBF-06BF3D61C3A2Q30491615-3E01D6CB-A96C-4033-B964-5D7A48B8E211Q30495474-A6FDC447-2F6F-4006-B71F-D22C5BF5286EQ30992792-EEADD6C6-4E0E-404C-8B91-969AB08D1DCCQ33604023-FF91B22C-9CB5-4D24-B60A-FA08BDDAF180Q33780519-D076D0E7-E891-4CF5-88C6-1C9F761F4FCBQ33783331-E13EF935-BA48-4259-A018-3748C1040AC5Q33783544-DF60BDF1-2F07-479C-AE54-D1149658E498Q33785302-33E95CE5-8115-4A29-9EEE-81C1A31582F9Q33785662-FBA1334A-CFA9-4A8A-8BED-60A218FEFAEFQ33795610-FE4911F9-E4C6-47A3-B2C6-55BCAA841A26Q33800960-8295AC20-3A83-4DB7-925D-ED794309E465Q33804963-786798C5-B295-464A-BDD6-D30326C35BB4Q33816167-0829B6CE-660D-4F3C-8138-A571625ACAB5Q33818125-3CCCC8BA-C787-4FA8-B667-8C2DCCC21214Q33842286-992F8D73-9A82-4CF9-847A-D9D036FEFA96Q33850330-F496ACA7-6538-4B5F-9DD5-32090EB5C23B
P2860
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Identification of a sequence r ...... virus type 1 RNA into virions
@ast
Identification of a sequence r ...... virus type 1 RNA into virions
@en
Identification of a sequence r ...... virus type 1 RNA into virions
@nl
type
label
Identification of a sequence r ...... virus type 1 RNA into virions
@ast
Identification of a sequence r ...... virus type 1 RNA into virions
@en
Identification of a sequence r ...... virus type 1 RNA into virions
@nl
prefLabel
Identification of a sequence r ...... virus type 1 RNA into virions
@ast
Identification of a sequence r ...... virus type 1 RNA into virions
@en
Identification of a sequence r ...... virus type 1 RNA into virions
@nl
P2860
P3181
P1433
P1476
Identification of a sequence r ...... virus type 1 RNA into virions
@en
P2093
P2860
P304
P3181
P407
P577
1989-09-01T00:00:00Z